Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL
- Status
- UNKNOWN
- Phase
- PHASE3
Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
- Status
- TERMINATED
- Phase
- PHASE1
The clonoSEQ® Watch Registry
- Status
- TERMINATED
- Phase
- N/A
Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Acalabrutinib and Obinutuzumab for the Treatment of Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Dose-Escalation and Dose-Expansion Study of ZX-101A in Patients With Relapsed/Resistant or Refractory Advanced Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)
- Status
- COMPLETED
- Phase
- PHASE3
Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of APG2575 Single Agent and Combination Therapy in Patients With Relapsed/Refractory CLL/SLL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
APR-246 in Combination With Acalabrutinib or Venetoclax Based Therapy in Subjects With R/R Non Hodgkin Lymphomas (NHL)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
MyPal ePRO-based Early Palliative Care System in Adult Patients With Hematologic Malignancies
- Status
- UNKNOWN
- Phase
- NA
First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL
- Status
- TERMINATED
- Phase
- N/A
Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab
- Status
- COMPLETED
- Phase
- PHASE2
Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A